Tranzyme

company

About

Tranzyme Pharma is a biopharmaceutical company focused on the discovery, development, and commercialization of mechanism-based therapies.

  • 11 - 50

Details

Last Funding Type
Series A
Industries
Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 1998
Number Of Employee
11 - 50
Operating Status
Active

Tranzyme Pharma is a biopharmaceutical company focused on the discovery, development, and commercialization of mechanism-based therapies. The company currently has programs for gastrointestinal motility disorders and retains worldwide rights for these programs. The company’s product portfolio includes, TZP-101, for the treatment of post-operative ileus and severe gastroparesis; and TZP-301, for the treatment of obesity and metabolic syndrome.

Tranzyme Pharma is based in North Carolina, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Tranzyme has raised a total of — in funding over 2 rounds. Their latest funding was raised on May 13, 2005 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 13, 2005 Series A 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Tranzyme is funded by 1 investors. Pacific Rim Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Pacific Rim Ventures Series A